Successful Treatment of Refractory Vasospastic Angina With Corticosteroids Coronary Arterial Hyperreactivity Caused by Local Inflammation?

case reports of refractory vasospastic angina resistant to intensive treatment with high doses of calcium antagonists and nitrates. Methods and Results Four patients with vasospastic angina, which was refractory to intensive treatment with high doses of calcium antagonists and nitrates, were completely controlled after administration of corticosteroids. Although none of the 4 patients showed eosinophilia, all had bronchial asthma or chronic thyroiditis, and in 2 cases, the activity of vasospastic angina corresponded with that of bronchial asthma. Conclusions These findings suggest that in these patients, coronary spasm may have been induced by arterial hyperreactivity because of local inflammation in the coronary arterial wall and that the corticosteroids suppressed the arterial hyperreactivity by alleviating the inflammation. Corticosteroids may be considered as a treatment choice for patients with refractory vasospastic angina, particularly when the patient has an allergic tendency, such as bronchial asthma. ( Circ J 2004; 68: 17–22)

[1]  Zhao Xiang-lian Inflammation and Acute Coronary Syndrome , 2003 .

[2]  Masahiro Ito,et al.  Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. , 2002, Journal of the American College of Cardiology.

[3]  Wolfgang Koenig,et al.  Inflammation and Coronary Heart Disease: An Overview , 2001, Cardiology in review.

[4]  P. Stone,et al.  A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). , 2000, European heart journal.

[5]  F. Fernández‐Avilés,et al.  Successful treatment of vasospastic angina with a coronary stent. , 2000, The Journal of invasive cardiology.

[6]  P. Creticos,et al.  Managing asthma in adults. , 2000, The American journal of managed care.

[7]  K. Suzuki,et al.  [Multi-vasospastic angina refractory to medical therapy caused by hyperthyroid stage of chronic thyroiditis and hypereosinophilia: a case report]. , 2000, Journal of cardiology.

[8]  R. Minshall,et al.  In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  K. Yamaguchi,et al.  [Coronary artery spasm during anesthetic induction in a patient with bronchial asthma]. , 1997, Masui. The Japanese journal of anesthesiology.

[10]  K. Hermsmeyer,et al.  Ca2+ release mechanism of primate drug-induced coronary vasospasm. , 1997, The American journal of physiology.

[11]  J. Rösch,et al.  Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm , 1997, Nature Medicine.

[12]  J. Webb,et al.  Stenting for treatment of coronary vasospasm. , 1996, Catheterization and cardiovascular diagnosis.

[13]  K. Shimizu,et al.  Efficacy of denopamine, a beta 1 adrenoceptor agonist, in preventing coronary artery spasm. , 1993, Japanese circulation journal.

[14]  M. Yamamoto,et al.  Refractory variant angina relieved by denopamine--a case report. , 1991, Japanese circulation journal.

[15]  J. Haft,et al.  Is coronary arterial spasm part of the aspirin-induced asthma syndrome? , 1986, Chest.

[16]  M. Nobuyoshi,et al.  Coronary artery spasm and vascular nerve lesion. , 1985, American heart journal.

[17]  R. Virmani,et al.  Increased adventitial mast cells in a patient with coronary spasm. , 1985, The New England journal of medicine.

[18]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[19]  M. Jazayeri,et al.  Asthma induced myocardial infarction in a patient with normal coronary arteries: a case report and a pathogenetic hypothesis. , 1983, Journal of medicine.

[20]  B. Gersh,et al.  Coronary artery spasm and myocardial infarction in the absence of angiographically demonstrable obstructive coronary disease. , 1981, Mayo Clinic proceedings.